1. Elevated Serum Levels of Soluble CD30 in Ankylosing Spondylitis Patients and Its Association with Disease Severity-Related Parameters
   Rongfen Gao et al, 2015, BioMed Research International CrossRef
2. Lack of Association between Genetic Polymorphisms of JAK-STAT Signaling Pathway Genes and Acute Anterior Uveitis in Han Chinese
   Ling Cheng et al, 2016, BioMed Research International CrossRef
3. Association of calreticulin expression with disease activity and organ damage in systemic lupus erythematosus patients
   Yichao Wang et al, 2017 CrossRef
4. Evaluation of the efficacy and safety of β- d -mannuronic acid in patients with ankylosing spondylitis: A 12-week randomized, placebo-controlled, phase I/II clinical trial
   Mohammad Javad Fattahi et al, 2018, International Immunopharmacology CrossRef
5. The Impact of Anti-TNF Therapy on CD4+ and CD8+ Cell Subsets in Ankylosing Spondylitis
   Sonja Dulic et al, 2017, Pathobiology CrossRef
6. Immune cells involved in the pathogenesis of ankylosing spondylitis.
   Alireza Rezaiemanesh et al, 2018, Biomed Pharmacother CrossRef
7. Functional Defects of Treg Cells: New Targets in Rheumatic Diseases, Including Ankylosing Spondylitis
   Jinlin Miao et al, 2018, Curr Rheumatol Rep CrossRef
8. IL-17 in the immunopathogenesis of spondyloarthritis
   Leonie S. Taams et al, 2018, Nat Rev Rheumatol CrossRef
9. Anti cytokine therapy in chronic inflammatory arthritis
   Charlotte Thompson et al, 2016, Cytokine CrossRef
10. Expansion and activation of monocytic-myeloid-derived suppressor cell via STAT3/arginase-I signaling in patients with ankylosing spondylitis
    Yu-feng Liu et al, 2018, Arthritis Res Ther CrossRef
11. The Use of Human Mesenchymal Stem Cells as Therapeutic Agents for the in vivo Treatment of Immune-Related Diseases: A Systematic Review
    Alessander Leyendecker Jr. et al, 2018, Front. Immunol. CrossRef
12. Ankylosing spondylitis and mesenchymal stromal/stem cell therapy: a new therapeutic approach
    Kamal Abdolmohammadi et al, 2019, Biomedicine & Pharmacotherapy CrossRef
13. Assessment of immunological profile in ankylosing spondylitis patients following a clinical trial with guluronic acid (G2013), as a new NSAID with immunomodulatory properties
    Seyed Shahabeddin Mortazavi-Jahromi et al, 2018, Immunol Res CrossRef
14. Nanocurcumin: A novel strategy in treating ankylosing spondylitis by modulating Th17 cells frequency and function
    Mehrzad Hajialilo et al, 2019, J Cell Biochem CrossRef
15. Treg cells in autoimmunity: from identification to Treg-based therapies
    Lisa Göschl et al, 2019, Semin Immunopathol CrossRef
16. The effects of nanocurcumin on Treg cell responses and treatment of ankylosing spondylitis patients: A randomized, double‐blind, placebo‐controlled clinical trial
    Majid Ahmadi et al, 2019, J Cell Biochem CrossRef
17. Functional defects in CD4+ CD25high FoxP3+ regulatory cells in ankylosing spondylitis.
    Huifang Guo et al, 0 CrossRef
18. Acquired pure red cell aplasia in a patient with ankylosing spondylitis- a case report and literature review
    Xianfang Shao et al, 2019, Medicine CrossRef
19. Ankylosing spondylitis: etiology, pathogenesis, and treatments.
    Wei Zhu et al, 2019, Bone Res CrossRef
20. Association Between Intercellular Adhesion Molecule-1, -2, -3 Plasma Levels and Disease Activity of Ankylosing Spondylitis in the Chinese Han Population
    Ruyin Liu et al, 2016, SPINE CrossRef
21. Circulating levels of Th1 and Th2 chemokines in patients with ankylosing spondylitis
    Jianing Wang et al, 2016, Cytokine CrossRef
22. Assay of Peripheral Regulatory Vδ1 T Cells in Ankylosing Spondylitis and its Significance
    Hongliang Wang et al, 2016, Med Sci Monit CrossRef
23. The Proportion of Regulatory T Cells in Patients with Ankylosing Spondylitis: A Meta-Analysis
    Na-Lin Lai et al, 2019, Journal of Immunology Research CrossRef
24. Treg-promoted New Bone Formation Through Suppressing TH17 by Secreting Interleukin-10 in Ankylosing Spondylitis
    Fan Xu et al, 2019, SPINE CrossRef
25. Oxidative stress and immunological biomarkers in Ankylosing spondylitis patients
    Shahla Danaii et al, 2019, Gene Reports CrossRef
26. Serum Deoxyribonuclease 1-like 3 is a potential biomarker for diagnosis of ankylosing spondylitis
    Yifan Sun et al, 2019, Clinica Chimica Acta CrossRef
27. Enhanced NETosis generation in radiographic axial spondyloarthritis: utility as biomarker for disease activity and anti-TNF-α therapy effectiveness
    Patricia Ruiz-Limon et al, 2020, J Biomed Sci CrossRef
28. TNF-α inhibitor therapy can improve the immune imbalance of CD4+ T cells and negative regulatory cells but not CD8+ T cells in ankylosing spondylitis
    Mingcan Yang et al, 2020, Arthritis Res Ther CrossRef
29. High frequency of circulating follicular helper T cells is correlated with B cell subtypes in patients with ankylosing spondylitis
    Siqi Long et al, 2018, Exp Ther Med CrossRef
30. Usefulness of complex bacteriological and serological analysis in patients with spondyloarthritis
    Daniela Cristea et al, 2019, Exp Ther Med CrossRef
31. Modulation of T-Cell Activation Markers Expression by the Adipose Tissue–Derived Mesenchymal Stem Cells of Patients with Rheumatic Diseases
    Ewa Kuca-Warnawin et al, 2020, Cell Transplant CrossRef
32. The Role of the IL-23/IL-17 Pathway in the Pathogenesis of Spondyloarthritis
    Hiroyuki Tsukazaki et al, 2020, IJMS CrossRef
33. Semaphorin 4D Induces an Imbalance of Th17/Treg Cells by Activating the Aryl Hydrocarbon Receptor in Ankylosing Spondylitis
    Jianmin Xie et al, 2020, Front. Immunol. CrossRef
34. Modulatory Impact of Adipose-Derived Mesenchymal Stem Cells of Ankylosing Spondylitis Patients on T Helper Cell Differentiation
    Ewa Kuca-Warnawin et al, 2021, Cells CrossRef
35. null
    Yang Du et al, 2021 CrossRef
36. Phenotypic characterization of circulating endothelial cells induced by inflammation and oxidative stress in ankylosing spondylitis
    Ayindrila Saha et al, 2021, Free Radical Research CrossRef
37. Osteoimmunological insights into the pathogenesis of ankylosing spondylitis
    Lifei Liu et al, 2021, J Cell Physiol CrossRef
38. Novel immune cell phenotypes in spondyloarthritis pathogenesis
    Daniele Mauro et al, 2021, Semin Immunopathol CrossRef
39. Role of the IL-23/IL-17 Pathway in Rheumatic Diseases: An Overview
    Claudia Schinocca et al, 2021, Front. Immunol. CrossRef
40. The gut-joint axis in spondyloarthritis: immunological, microbial, and clinical insights
    Zoya Qaiyum et al, 2021, Semin Immunopathol CrossRef
41. Recent Updates in the Immunopathology of Type 3 Immunity-Mediated Enthesitis
    Akihiro Nakamura et al, 2021, Curr Rheumatol Rep CrossRef
42. Anti-IL-17 Agents in the Treatment of Axial Spondyloarthritis
    Fabiola Atzeni et al, 2021, ITT CrossRef
43. Potential Role and Impact of Peripheral Blood Mononuclear Cells in Radiographic Axial Spondyloarthritis-Associated Endothelial Dysfunction
    Patricia Ruiz-Limon et al, 2021, Diagnostics CrossRef
44. null
    Maryam Akhtari, 2022 CrossRef
45. Cellular and molecular diversity in spondyloarthritis
    G.R. Gulino et al, 2021, Seminars in Immunology CrossRef
46. The role of IL-17 and anti-IL-17 agents in the immunopathogenesis and management of autoimmune and inflammatory diseases
    S.P. Déo-Gracias Berry et al, 2021, International Immunopharmacology CrossRef
47. Elevated Th17 cells are associated with cardiovascular complications in ankylosing spondylitis
    Tingting Ding et al, 2021 CrossRef
48. Interleukin-35 promotes Breg expansion and interleukin-10 production in CD19+ B cells in patients with ankylosing spondylitis
    Yu Zhang et al, 2022, Clin Rheumatol CrossRef
49. FOXO3a Alleviates the Inflammation and Oxidative Stress via Regulating TGF-β and HO-1 in Ankylosing Spondylitis
    Shanshan Xu et al, 2022, Front. Immunol. CrossRef
50. Efficacy and Safety of Curcumin and Curcuma longa Extract in the Treatment of Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trial
    Liuting Zeng et al, 2022, Front. Immunol. CrossRef
51. Curcumin and Curcuma longa Extract in the Treatment of 10 Types of Autoimmune Diseases: A Systematic Review and Meta-Analysis of 31 Randomized Controlled Trials
    Liuting Zeng et al, 2022, Front. Immunol. CrossRef
52. Ezetimibe ameliorates clinical symptoms in a mouse model of ankylosing spondylitis associated with suppression of Th17 differentiation
    Jeonghyeon Moon et al, 2022, Front. Immunol. CrossRef
53. How Has Molecular Biology Enhanced Our Undertaking of axSpA and Its Management
    Mauro Fatica et al, 2022, Curr Rheumatol Rep CrossRef
54. Janus Kinase Inhibitors: A New Tool for the Treatment of Axial Spondyloarthritis
    Marino Paroli et al, 2023, IJMS CrossRef
55. A Predictive Disease Risk Model for Ankylosing Spondylitis: Based on Integrated Bioinformatic Analysis and Identification of Potential Biomarkers Most Related to Immunity
    Wenxin Gao et al, 2023, Mediators of Inflammation CrossRef
56. Screening and identification of key chromatin regulator biomarkers for ankylosing spondylitis and drug prediction: evidence from bioinformatics analysis
    Han Wang et al, 2023, BMC Musculoskelet Disord CrossRef
57. Platelet-Derived Microparticles and Autoimmune Diseases
    Xiaoshuai Li et al, 2023, IJMS CrossRef
58. Evaluation of cell adhesion molecules (LFA-1 and L-selectin) in ankylosing spondylitis patients after treatment with β-D-mannuronic acid (M2000)
    MohammadJavad Fattahi et al, 2023, Indian J Med Res CrossRef
59. Association between ankylosing spondylitis and m6A methylation
    Zhiwei Luan et al, 2023, J Orthop Surg Res CrossRef
60. Regulatory T cells in spondyloarthropathies: genetic evidence, functional role, and therapeutic possibilities
    Stefano Rodolfi et al, 2024, Front. Immunol. CrossRef
61. An ankylosing spondylitis-associated genetic variant in the IL23R-IL12RB2 intergenic region modulates enhancer activity and is associated with increased Th1-cell differentiation.
    Amity R Roberts et al, 2016, Ann Rheum Dis CrossRef
62. Single-cell transcriptome revealed dysregulated RNA-binding protein expression patterns and functions in human ankylosing spondylitis
    Zheng Ren et al, 2024, Front. Med. CrossRef
63. Acute promyelocytic leukemia with additional chromosome abnormalities in a patient positive for HIV: A case report and literature review
    Xiao-Lan Li et al, 2024, Oncol Lett CrossRef
64. Therapeutic potential of single-nucleotide polymorphism-mediated IL6R inhibitors in ankylosing spondylitis treatment
    Ding-Qiang Chen et al, 2024, Front. Med. CrossRef
65. Application of neutrophil to lymphocyte ratio in ankylosing spondylitis: Based on bibliometric and visualization analysis
    Cong Chengzhi et al, 2024 CrossRef
66. Myeloid-derived suppressor cells in axial spondyloarthritis patients with different types of therapy
    A. Yu. Morenkova et al, 2024, Naučno-praktičeskaâ revmatologiâ CrossRef
67. Role of Curcuma longae Rhizoma in medical applications: research challenges and opportunities
    Peng Zhang et al, 2024, Front. Pharmacol. CrossRef
68. The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controversies
    Dennis G McGonagle et al, 2019, Ann Rheum Dis CrossRef
69. Investigating the causal relationship between immune factors and ankylosing spondylitis: insights from a Mendelian Randomization study
    Ziming Geng et al, 2024, Adv Rheumatol CrossRef
70. Meta‐Analysis of Changes in the Number and Proportion of Regulatory T Cells in Patients with Ankylosing Spondylitis
    Ming Li et al, 2020, BioMed Research International CrossRef